Human Psychopharmacology: Clinical and Experimental 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.---
Human Psychopharmacology: Clinical and Experimental, Ahead of Print. (Source: Human Psychopharmacology: Clinical and Experimental)
Source: Human Psychopharmacology: Clinical and Experimental - March 11, 2018 Category: Psychiatry Source Type: research
Using the Severity of Dependence Scale to screen for DSM ‐5 khat use disorder
ConclusionAlthough khat is a mild stimulant, there is clear evidence that some consumers are both concerned with their use and experience problems associated with their use. Consistent with its application for other drugs, the SDS is a brief and simple screening tool that appears to validly identify individuals experiencing a khat use disorder syndrome and experiencing high rates of adverse consequences in association with use. (Source: Human Psychopharmacology: Clinical and Experimental)
Source: Human Psychopharmacology: Clinical and Experimental - March 11, 2018 Category: Psychiatry Authors: Samson W. Duresso, Allison J. Matthews, Stuart G. Ferguson, Raimondo Bruno Tags: RESEARCH ARTICLE Source Type: research
Alcohol mixed with energy drink (AMED): A critical review and meta ‐analysis
Human Psychopharmacology: Clinical and Experimental,Volume 33, Issue 2, March 2018. (Source: Human Psychopharmacology: Clinical and Experimental)
Source: Human Psychopharmacology: Clinical and Experimental - February 8, 2018 Category: Psychiatry Source Type: research
---
Human Psychopharmacology: Clinical and Experimental, Ahead of Print. (Source: Human Psychopharmacology: Clinical and Experimental)
Source: Human Psychopharmacology: Clinical and Experimental - February 8, 2018 Category: Psychiatry Source Type: research
Serum levels of interleukin 6 in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study)
Human Psychopharmacology: Clinical and Experimental,Volume 33, Issue 2, March 2018. (Source: Human Psychopharmacology: Clinical and Experimental)
Source: Human Psychopharmacology: Clinical and Experimental - February 7, 2018 Category: Psychiatry Source Type: research
---
Human Psychopharmacology: Clinical and Experimental, Ahead of Print. (Source: Human Psychopharmacology: Clinical and Experimental)
Source: Human Psychopharmacology: Clinical and Experimental - February 7, 2018 Category: Psychiatry Source Type: research
Serum levels of interleukin 6 in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study)
ConclusionsSarcosine does not significantly affect IL‐6 concentrations but IL‐6 may be involved in mechanisms related to the presence of positive symptoms. (Source: Human Psychopharmacology: Clinical and Experimental)
Source: Human Psychopharmacology: Clinical and Experimental - February 7, 2018 Category: Psychiatry Authors: Dominik Strzelecki, Ma łgorzata Urban‐Kowalczyk, Adam Wysokiński Tags: RESEARCH ARTICLE Source Type: research
---
Human Psychopharmacology: Clinical and Experimental,Volume 33, Issue 1, January 2018. (Source: Human Psychopharmacology: Clinical and Experimental)
Source: Human Psychopharmacology: Clinical and Experimental - January 26, 2018 Category: Psychiatry Source Type: research
Effects of caffeinated alcoholic beverages with low alcohol and high caffeine content on cognitive and motor functions
(Source: Human Psychopharmacology: Clinical and Experimental)
Source: Human Psychopharmacology: Clinical and Experimental - January 26, 2018 Category: Psychiatry Tags: CORRIGENDUM Source Type: research
Issue Information
No abstract is available for this article. (Source: Human Psychopharmacology: Clinical and Experimental)
Source: Human Psychopharmacology: Clinical and Experimental - January 26, 2018 Category: Psychiatry Tags: ISSUE INFORMATION Source Type: research
Learning and memory performance following acute intranasal insulin administration in abstinent smokers
Human Psychopharmacology: Clinical and Experimental,Volume 33, Issue 2, March 2018. (Source: Human Psychopharmacology: Clinical and Experimental)
Source: Human Psychopharmacology: Clinical and Experimental - January 24, 2018 Category: Psychiatry Source Type: research
---
Human Psychopharmacology: Clinical and Experimental, Ahead of Print. (Source: Human Psychopharmacology: Clinical and Experimental)
Source: Human Psychopharmacology: Clinical and Experimental - January 24, 2018 Category: Psychiatry Source Type: research
Consensus statements on the clinical understanding and use of milnacipran in Hong Kong
Human Psychopharmacology: Clinical and Experimental,Volume 33, Issue 2, March 2018. (Source: Human Psychopharmacology: Clinical and Experimental)
Source: Human Psychopharmacology: Clinical and Experimental - January 17, 2018 Category: Psychiatry Source Type: research
